EDGAR Filing Documents for 0001683168-18-003505

Form 8-K - Current report:

SEC Accession No. 0001683168-18-003505

Filing Date

2018-11-19

Accepted

2018-11-19 17:00:13

Documents

Period of Report

2018-11-14

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	phio_8k.htm	8-K	33356
2	CERTIFICATE OF AMENDMENT	phio_ex0301.htm	EX-3.1	4713
3	AMENDED AND RESTATED CERTIFICTE OF INCORPORATION	phio_ex0302.htm	EX-3.2	24760
4	AMENDED AND RESTATED BYLAWS	phio_ex0303.htm	EX-3.3	61923
5	SPECIMEN STOCK CERTIFICATE	phio_ex0304.htm	EX-3.4	6331
6	PRESS RELEASE	phio_ex9901.htm	EX-99.1	9272
7	GRAPHIC	image_003.jpg	GRAPHIC	104621
8	GRAPHIC	image_002.jpg	GRAPHIC	3164
	Complete submission text file	0001683168-18-003505.txt		290549

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752

Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861

Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)